Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Bentley launches Torcal as luxury rivals pull back on electric cars

    September 24, 2026

    No Kings But King Dollar

    September 24, 2026

    Ukraine: Russia welcomes U.S. invite for possible Trump-Putin meeting

    September 24, 2026
    Facebook X (Twitter) Instagram
    Addison Markets Addison Markets
    • Home
    • USA
    • Europe
    • Business
    • Investing
    • Tech
    • Politics
    • Contact Us
    Addison Markets Addison Markets
    Home»Tech»RFK Jr.’s hand-picked committee approves manufacture of peptides he uses
    Tech

    RFK Jr.’s hand-picked committee approves manufacture of peptides he uses

    franperez66q@protonmail.comBy franperez66q@protonmail.comJuly 24, 2026No Comments2 Mins Read
    Facebook Twitter Pinterest Telegram LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn Pinterest Telegram Email



    RFK Jr. and many like him, who fear the clearly defined and well-understood proteins in vaccines, are perfectly willing to inject various peptides in the complete absence of any safety data. However, unlike most of the peptide fans who share anecdotes online, Kennedy is in a position to turn his hobby into policy.

    While the FDA has already used its standard processes to approve peptide drugs like insulin and some recently developed weight loss drugs, the lack of safety and efficacy data has kept most peptides off the market. The Biden administration also blocked their manufacture by compounding pharmacies, which make specialty drugs. But, earlier this year, Kennedy announced his interest in reversing that ban.

    At the time of his announcement, Ars’ Beth Mole wrote, “Outside experts and watchdogs suspect that before the first meeting in July, Kennedy will work to stack the advisory board with questionably qualified allies who will come with a predetermined decision to ease access to the drugs—no rigorous scientific evaluation needed.” That’s exactly what came to pass. In June, Kennedy added members to the advisory group who, with one exception, had obvious interests in the manufacture and sale of the unapproved peptides.

    Yesterday, those newly appointed members provided the decisive votes for overturning the ban, with all of the pre-Kennedy members voting against doing so. Despite Kennedy’s earlier claim that “independent experts will rigorously evaluate each substance on its scientific merits using full clinical, pharmacological, and safety evidence,” no such evidence was presented at the meeting.

    According to The New York Times, when asked by a committee member whether the FDA had ever approved anything that had never been tested in humans before, an FDA official said it had not. That may be a critical factor in what happens next. The committee’s role is advisory, and the FDA could reject its recommendations. Doing so, however, would place the FDA’s experts in direct conflict with the wishes of Kennedy, who can simply fire them.



    Source link

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    franperez66q@protonmail.com
    • Website

    Related Posts

    Ukrainian drones overwhelm Russian tanks’ new active protection system—for now

    August 19, 2026

    Jim Cramer says the market is too negative — and that’s creating buying opportunities

    August 19, 2026

    “Sabotage”: Experts, lawmakers blast RFK Jr. for destroying healthcare research

    August 18, 2026

    OpenAI rolls out ChatGPT for Teens with more safety protections

    August 18, 2026

    Against all odds, SpaceX finally tugs Starship into port after 24 days at sea

    August 18, 2026

    Economists warn AI-driven market rally is due a sharp correction

    August 18, 2026
    Leave A Reply Cancel Reply

    Top Reviews
    Editors Picks

    Bentley launches Torcal as luxury rivals pull back on electric cars

    September 24, 2026

    No Kings But King Dollar

    September 24, 2026

    Ukraine: Russia welcomes U.S. invite for possible Trump-Putin meeting

    September 24, 2026

    Swiss National Bank holds rates at 0% as inflation stays low

    September 24, 2026
    © 2026 All right reserved
    • Privacy Policy
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.